Security key
05338F306
Avalo Therapeutics, Inc. - Common Stock, par value $0.001 per share (AVTX)
CUSIP: 05338F306
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 87,507
- Total 13F value
- $1,897,924
- Share change
- +64,537
- SEC-reported price per share
- $21.75
- Number of holders
- 18
- Value change
- +$1,405,693
- Number of buys
- 10
- Number of sells
- 6
- Shares outstanding
- 57,788,980
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
18
Top holders
10
AVTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2024
Previous quarter: Q4 2023
Avalo Therapeutics, Inc. SEC filings
Avalo Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05338F306
Recent filing periods:
Ownership snapshot
Top reported holders of AVTX - Avalo Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
12/15
Latest evidence
31 Dec 2023
13F
3/4/5
Lead comparable stake: 0.03%
3 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. leads the comparable SEC ownership view at 0.03%.
12 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock Finance, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock Finance, Inc.
0.03%
NATIXIS
0.01%
Tower Research Capital LLC (TRC)
0%
FNY Investment Advisers, LLC
0%
ROYAL BANK OF CANADA
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
0.03%
|
$144,472
15,876 shares
|
— | 31 Dec 2023 |
| NATIXIS |
13F
Company
|
0.01%
|
$43,278
4,604 shares
|
— | 31 Dec 2023 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0%
|
$16,071
1,766 shares
|
— | 31 Dec 2023 |
| FNY Investment Advisers, LLC |
13F
Company
|
0%
|
$4,000
522 shares
|
— | 31 Dec 2023 |
| ROYAL BANK OF CANADA |
13F
Company
|
0%
|
$1,000
138 shares
|
— | 31 Dec 2023 |
| MORGAN STANLEY |
13F
Company
|
0%
|
$400
44 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
18
Shares
87,507
Rows available
18
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
12
Q1 2024 holders
18
Holder diff
6
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend